DRTSW

Insider Trades

Name	Value	Action	Price	Current Price
Levy RaphiChief Financial Officer $191k17.5k shares SellJun 3, 2026 $10.90 --
Levy RaphiChief Financial Officer $161k15k shares SellJun 3, 2026 $10.76 --

Trade DRTSW

About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd. is a clinical-stage biopharmaceutical company dedicated to the research, development, and eventual commercialization of innovative cancer treatments. Its primary focus is on Alpha DaRT (diffusing alpha-emitters radiation therapy), a novel approach designed to effectively treat solid tumors. The company's initial commercialization efforts are concentrated in Israel and the United States. Currently, Alpha DaRT is undergoing clinical trials for various malignancies, including skin, oral, pancreatic, and breast cancers. Beyond this, preclinical studies are investigating its potential efficacy against hepatic cell carcinoma, lung, and prostate cancers. Established in 2015, Alpha Tau Medical maintains its headquarters in Jerusalem, Israel.

CEO: Uzi Sofer
IPO Date: Mar 8, 2022

Market Data

Open: $1.84
High: $1.96
Low: $1.81
Volume: 16.9K
Avg Volume: 31.2K
52W High: $2.14
52W Low: $0.3251

Valuation

Market Cap: $883M
Enterprise Value: $889M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-33M
Revenue: $0
Net Income: $-43M
Cash: $16M
Debt: $14M

Events

EarningsAug 18

EPS est. -0.14088